European patent for Spectraphos:
This article was originally published in Clinica
Executive Summary
Xillix Technologies' newly-acquired Swedish subsidiary, Spectraphos, has been awarded European patent coverage for Xillix' tissue fluorescence imaging technology. According to Pierre Leduc, president and CEO of the Canadian company: "This patent provides additional protection for Xillix' LIFE Imaging System."